The Validity of Kleinhauer Betke in Women With Known Hemoglobinopathy for Fetal-maternal Hemorrhage

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03591640

Enrollment

Registered

2018-07-19

Start date

2018-07-18

Completion date

2021-04-28

Last updated

2022-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal-Maternal Hemorrhage

Brief summary

The aim of this study is to determine the validity of Kleinhauer Betke in women with known hemoglobinopathy for fetal-maternal hemorrhage.

Interventions

DIAGNOSTIC_TESTBlood test

Standard blood test

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Pregnant with singleton fetus * Gestational age 34-42 * With or without known hemoglobinopathy

Exclusion criteria

* Known risk factor for fetal maternal hemorrhage

Design outcomes

Primary

Measure	Time frame	Description
Validity of Kleinhauer Betke test in Pregnant Women	24 hours	Comparison of Kleinhauer Betke results with electrophoresis results to determine presence of F-hemoglobin. This would indicate the validity of the Kleinhauer Betke test in women with hemoglobinopathy

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026